These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 33777743)
1. The Prognostic Value of Plasma Cell-Free DNA Concentration in the Prostate Cancer: A Systematic Review and Meta-Analysis. Liu H; Gao Y; Vafaei S; Gu X; Zhong X Front Oncol; 2021; 11():599602. PubMed ID: 33777743 [TBL] [Abstract][Full Text] [Related]
2. Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. Spindler KG; Boysen AK; Pallisgård N; Johansen JS; Tabernero J; Sørensen MM; Jensen BV; Hansen TF; Sefrioui D; Andersen RF; Brandslund I; Jakobsen A Oncologist; 2017 Sep; 22(9):1049-1055. PubMed ID: 28778958 [TBL] [Abstract][Full Text] [Related]
3. Glutathione-S-Transferase Ye J; Wu M; He L; Chen P; Liu H; Yang H Int J Endocrinol; 2023; 2023():7279243. PubMed ID: 36747996 [TBL] [Abstract][Full Text] [Related]
4. Cell-free DNA as a Promising Diagnostic Biomarker in Prostate Cancer: A Systematic Review and Meta-Analysis. Zhang C; Chao F; Wang S; Han D; Chen G J Oncol; 2022; 2022():1505087. PubMed ID: 35669243 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis. Tan G; Chu C; Gui X; Li J; Chen Q Medicine (Baltimore); 2018 Mar; 97(13):e0197. PubMed ID: 29595655 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-Lymphocyte Ratio Predicts PSA Response and Prognosis in Prostate Cancer: A Systematic Review and Meta-Analysis. Cao J; Zhu X; Zhao X; Li XF; Xu R PLoS One; 2016; 11(7):e0158770. PubMed ID: 27368058 [TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer. He X; Chi Y; Peng J; Hu W; Ding C; Li B J Thorac Dis; 2022 Jun; 14(6):2103-2111. PubMed ID: 35813759 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis. Li B; Pu K; Ge L; Wu X Gene; 2019 Sep; 714():143993. PubMed ID: 31330238 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis. Zhuang R; Li S; Li Q; Guo X; Shen F; Sun H; Liu T PLoS One; 2017; 12(8):e0182562. PubMed ID: 28796802 [TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Circulating Cell-Free DNA in Colorectal Cancer: A Meta-Analysis. Basnet S; Zhang ZY; Liao WQ; Li SH; Li PS; Ge HY J Cancer; 2016; 7(9):1105-13. PubMed ID: 27326254 [TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis. Xie W; Xie L; Song X Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of Concentration of Circulating Cell-Free DNA in Breast Cancer: A Meta-Analysis. Yu D; Tong Y; Guo X; Feng L; Jiang Z; Ying S; Jia J; Fang Y; Yu M; Xia H; Shi L; Lou J Front Oncol; 2019; 9():95. PubMed ID: 30881916 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of cell-free DNA accuracy as diagnostic biomarker for prostate cancer: A systematic review and meta-analysis. Chen C; Chen C; Sadeghi M Biotechnol Appl Biochem; 2022 Apr; 69(2):749-766. PubMed ID: 33749048 [TBL] [Abstract][Full Text] [Related]
14. The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis. Li Y; Huang Q; Zhou Y; He M; Chen J; Gao Y; Wang X Front Pharmacol; 2018; 9():1494. PubMed ID: 30733677 [No Abstract] [Full Text] [Related]
15. Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients. Hendriks RJ; Dijkstra S; Smit FP; Vandersmissen J; Van de Voorde H; Mulders PFA; van Oort IM; Van Criekinge W; Schalken JA Prostate; 2018 Apr; 78(5):336-342. PubMed ID: 29330943 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis. Stafford MYC; Willoughby CE; Walsh CP; McKenna DJ Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34931228 [TBL] [Abstract][Full Text] [Related]
17. A Systematic Review and Meta-Analysis on the Predictive Value of Cell-Free DNA-Based Androgen Receptor Copy Number Gain in Patients With Castration-Resistant Prostate Cancer. Tolmeijer SH; Boerrigter E; Schalken JA; Geerlings MJ; van Oort IM; van Erp NP; Gerritsen WR; Ligtenberg MJL; Mehra N JCO Precis Oncol; 2020 Nov; 4():714-729. PubMed ID: 35050750 [TBL] [Abstract][Full Text] [Related]
18. Meta-Analysis of Circulating Cell-Free DNA's Role in the Prognosis of Pancreatic Cancer. Milin-Lazovic J; Madzarevic P; Rajovic N; Djordjevic V; Milic N; Pavlovic S; Veljkovic N; Milic NM; Radenkovic D Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298594 [TBL] [Abstract][Full Text] [Related]
19. Prognostic value of a baseline prognostic nutritional index for patients with prostate cancer: a systematic review and meta-analysis. Zheng Y; Wang K; Ou Y; Hu X; Wang Z; Wang D; Li X; Ren S Prostate Cancer Prostatic Dis; 2024 Dec; 27(4):604-613. PubMed ID: 37391595 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum alkaline phosphatase in the survival of prostate cancer: evidence from a meta-analysis. Li D; Lv H; Hao X; Hu B; Song Y Cancer Manag Res; 2018; 10():3125-3139. PubMed ID: 30214305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]